Rasagilin Accord 1 mg Tabletten

Recall | Medicines | 05/09/2022

The marketing authorisation holder informed its customers on September 02, 2022 that the nitrosamine levels of the listed batch is above the permitted acceptable daily dose.  As a precautionary measure, the affected batch is recalled.

Name of the medicinal product Rasagilin Accord 1 mg Tabletten
Marketing authorisation number(s) 136675
CIP code 4231995
Marketing authorisation holder Accord Healthcare B.V.
Batch number(s) 00032A
Expiry date 01/31/2023
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-3816

Further inquiry note